Applied Therapeutics, Inc. - מכפיל EV/Sales APLT

לוגו של חברה ציבורית Applied Therapeutics Inc. (APLT)

Applied Therapeutics develops drugs for rare metabolic pathologies, betting on the high margins of orphan products. This price-to-sales ratio chart illustrates the asset's dynamics, where 5410.00 serves as the current parameter value. The business relies on sales of medications for the treatment of galactosemia, however, a critical dependence on FDA verdicts creates binary risks amid borderline liquidity levels.

Applied Therapeutics, Inc. - יחס שווי פעילות להכנסות APLT (תקופה 23.11.2025 - 16.02.2026)

appliedtherapeutics.com - פילוחים אנליטיים ומדדי מפתח (APLT)

ניתוח ראשוני של החברה:appliedtherapeutics.com
מוצר סדרתי של Applied Therapeutics

Applied Therapeutics possesses monopoly potential due to the market launch of unique drugs for the treatment of rare metabolic diseases. An analysis of the current EV/Sales ratio allows for the valuation of the entire business relative to revenue, excluding the impact of debt load, which helps investors determine the fair price of the asset and identify either the company's undervaluation or risks of structural decline.